Scolaris Content Display Scolaris Content Display

Маневр Эпли (репозиционирование отолитов канала) при доброкачественном пароксизмальном позиционном головокружении (ДППГ)

Contraer todo Desplegar todo

Referencias

Amor Dorado 2012 {published data only}

Amor‐Dorado JC, Barreira‐Fernandez MP, Aran‐Gonzalez I, Casariego‐Vales E, Llorca J, Gonzalez‐gay MA. Particle repositioning maneuver versus Brandt‐Daroff exercise for treatment of unilateral idiopathic BPPV of the posterior semicircular canal: a randomized prospective clinical trial with short‐ and long‐term outcome. Otology & Neurotology 2012;33:1401‐7.

Bruintjes 2014 {published data only}

Bruintjes TD, Companjen J, van der Zaag‐Loonen HJ, van Benthem PP. A randomised sham‐controlled trial to assess the long‐term effect of the Epley manoeuvre for treatment of posterior canal BPPV. Clinical Otolaryngology 2014;1:39‐44.

Dispenza 2012 {published data only (unpublished sought but not used)}

Dispenza F, Dulamarva G, De Stefano A. Comparison of repositioning maneuvers for benign paroxysmal positional vertigo of posterior semicircular canal: advantages of hybrid maneuver. American Journal of Otolaryngology 2012;33:528‐32.

Froehling 2000 {published data only}

Froehling DA, Bowen JM, Mohr DN, Brey RH, Beatty CW, Wollan PC, et al. The canalith repositioning procedure for the treatment of benign paroxysmal positional vertigo: a randomized controlled trial. Mayo Clinic Proceedings 2000;75(7):695‐700.

Liang 2010 {published data only}

Liang S‐B, Li L, He H‐Y. The efficacy of Epley procedure for treatment of benign paroxysmal positional vertigo of the posterior semicircular canal. Journal of Youjiang Medical University for Nationalities 2010;2:7.

Lynn 1995 {published data only}

Lynn S, Pool A, Rose D, Brey R, Suman V. Randomized trial of the canalith repositioning procedure. Otolaryngology ‐ Head and Neck Surgery 1995;113(6):712‐20.

Mazoor 2011 {published data only}

Mazoor T, Niazi SB. Efficacy of Semont manoeuvre versus Epley manoeuvre in benign paroxysmal positional vertigo. Pakistan Armed Forces Medical Journal 2011;61:251‐4.

Munoz 2007 {published data only (unpublished sought but not used)}

Munoz J, Miklea J, Howard M, Springate R, Kaczorowski J. Canalith repositioning maneuver for benign paroxysmal positional vertigo. Canadian Family Physician 2007;53:1048‐53.

von Brevern 2006 {published data only}

von Brevern M, Seelig T, Radtke A, Tiel‐Wilck K, Neuhauser H, Lempert T. Short‐term efficacy of Epley's manoeuvre: a double‐blind randomised trial. Journal of Neurology, Neurosurgery and Psychiatry 2006;77:980‐2.

Xie 2012 {published data only}

Xie K, Du S‐W, Gao J‐J, Shou G‐l, Jian H‐Y, Li Y‐Z. Clinical efficacy of Epley procedure for treatment of benign paroxysmal positional vertigo of posterior semicircular canal. Chinese Journal of General Practice 2012;2:20.

Yimtae 2003 {published data only}

Yimtae K, Srirompotong S, Srirompotong S, Sae‐seaw P. A randomized trial of the canalith repositioning procedure. Laryngoscope 2003;113:828‐32.

Angeli 2003 {published data only}

Angeli S, Hawley R, Gomez O. Systematic approach to benign paroxysmal positional vertigo in the elderly. Otolaryngology ‐ Head and Neck Surgery 2003;128:719‐25.

Arbağ 2003 {published data only}

Arbağ H, Özer B, Keleş B, Ülkü ÇH, Öztürk K. The comparison of the Semont and Epley maneuvers used in the treatment of BPPV. KBB‐Forum 2003;2(3):44‐9.

Asawavichianginda 2000 {published data only}

Asawavichianginda S, Isipradit P, Snidvongs K, Supiyaphun P. Canalith repositioning for benign paroxysmal positional vertigo: a randomized, controlled trial. Ear, Nose, and Throat Journal 2000;79(9):732‐4, 736‐7.

Blakley 1994 {published data only}

Blakley BW. A randomized, controlled assessment of the canalith repositioning maneuver [see comments]. Otolaryngology ‐ Head and Neck Surgery 1994;110(4):391‐6.

Cohen 1999 {published data only}

Cohen HS, Jerabek J. Efficacy of treatments for posterior canal benign paroxysmal positional vertigo. Laryngoscope 1999;109(4):584‐90.

Cohen 2005 {published data only}

Cohen HS, Kimball KT. Effectiveness of treatments for benign paroxysmal positional vertigo of the posterior canal. Otology and Neurotology 2005;26(5):1034‐40.

Herdman 1993 {published data only}

Herdman SJ, Tusa RJ, Zee DS, Proctor LR, Mattox DE. Single treatment approaches to benign paroxysmal positional vertigo. Archives of Otolaryngology ‐ Head and Neck Surgery 1993;119(4):450‐4.

Li 1995 {published data only}

Li JC. Mastoid oscillation: a critical factor for success in the canalith repositioning procedure. Otolaryngology ‐ Head and Neck Surgery 1995;112:670‐5.

Massoud 1996 {published data only}

Massoud EA, Ireland DJ. Post‐treatment instructions in the nonsurgical management of benign paroxysmal positional vertigo. Journal of Otolaryngology 1996;25(2):121‐5.

Radtke 1999 {published data only}

Radtke A, Neuhauser H, von Brevern M, Lempert T. A modified Epley's procedure for self‐treatment of benign paroxysmal positional vertigo. Neurology 1999;53(6):1358‐60.

Sekine 2006 {published data only}

Sekine K, Imai T, Sato G, Ito M, Takeda N. Natural history of benign paroxysmal positional vertigo and efficacy of Epley and Lempert manoeuvres. Otolaryngology ‐ Head and Neck Surgery 2006;135:529‐33.

Seo 2007 {published data only}

Seo T, Miyamoto A, Saka N, Shimano K, Sakagami M. Immediate efficacy of the canalith repositioning procedure for the treatment of benign paroxysmal positional vertigo. Otology & Neurotology 2007;28(7):917‐9.

Sherman 2001 {published data only}

Sherman D, Massoud E. Treatment outcomes of benign paroxysmal positional vertigo. Journal of Otolaryngology 2001;30(5):295‐9.

Soto Varela 2001 {published data only}

Soto Varela A, Bartual Magro J, Santos Perez S, Velez Regueiro M, Lechuga Garcia R, Perez‐Carro Rios TA, et al. Benign paroxysmal vertigo: a comparative prospective study of the efficacy of Brandt and Daroff exercises, Semont and Epley manoeuvre [Vertige positionnel paroxystique benin: etude comparative prospective sur l'efficacite des exercises de Brandt et Daroff, la manoeuvre de Semont et la manoeuvre d'Epley]. Revue de Laryngologie, Otologie, Rhinologie 2001;122(3):179‐83.

Sridhar 2003 {published data only}

Sridhar S, Panda N, Raghunathan M. Efficacy of particle repositioning maneuver in BPPV: a prospective study. American Journal of Otolaryngology 2003;24(6):355‐60.

Steenerson 1996 {published data only}

Steenerson RL, Cronin GW. Comparison of the canalith repositioning procedure and vestibular habituation training in forty patients with benign paroxysmal positional vertigo. Otolaryngology ‐ Head and Neck Surgery 1996;114(1):61‐4.

Waleem 2008 {published data only}

Waleem SSU, Malik SM, Ullah S, Hassan Z. Office management of benign paroxysmal positional vertigo with Epley's manoeuvre. Journal of Ayub Medical College, Abbottabad 2008;20(1):77‐9.

Wolf 1999 {published data only}

Wolf M, Hertanu T, Novikov I, Kronenberg J. Epley's manoeuvre for benign paroxysmal positional vertigo: a prospective study. Clinical Otolaryngology 1999;24(1):43‐6.

References to studies awaiting assessment

Dashti Gholamali 2010 {published data only}

Dashti Gholamali AA. Comparison of Epley and Semont maneuver in the treatment of patients with BPPV. Iranian Journal of Otorhinolaryngology 2010;21(57,58 Suppl):29.

Okhovat 2003 {published data only}

Okhovat A, Berjis N, Naghdi S. Assessment and comparison of the effectiveness of Epley and Semont maneuvers in treatment of benign paroxysmal positional vertigo (BPPV). Journal of Isfahan Medical School (I.U.M.S) 2003;26:69‐70.

Baloh 1987

Baloh RW, Honrubia V, Jacobson K. Benign positional vertigo: clinical and oculographic features in 240 cases. Neurology 1987;37(3):371‐8.

Bhattacharyya 2008

Bhattacharyya N, Baugh RF, Orvidas L, Barrs D, Bronston LJ, Cass S, et al. Clinical practice guideline: benign paroxysmal positional vertigo. Otolaryngology ‐ Head and Neck Surgery 2008;139:S47‐S81.

Brandt 1980

Brandt T, Daroff RB. Physical therapy for benign paroxysmal positional vertigo. Archives of Otolaryngology 1980;106(8):484‐5.

Brandt 1999

Brandt T. Vestibular dysfunction and its therapy: Benign paroxysmal positional vertigo. In: Büttner U editor(s). Advances in Otorhinolaryngology. Vol. 55, Basel: Karger, 1999:169‐94.

Dix 1952

Dix R, Hallpike CS. The pathology, symptomatology and diagnosis of certain common disorders of the vestibular system. Annals of Otology, Rhinology and Laryngology 1952;6:987‐1016.

Epley 1992

Epley JM. The canalith repositioning procedure: for treatment of benign paroxysmal positional vertigo. Otolaryngology ‐ Head and Neck Surgery 1992;107(3):399‐404.

Froehling 1991

Froehling DA, Silverstein MD, Mohr DN, Beatty CW, Offord KP, Ballard DJ. Benign positional vertigo: incidence and prognosis in a population‐based study in Olmsted County, Minnesota. Mayo Clinic Proceedings 1991;66(6):596‐601.

Halker 2008

Halker RB, Barrs DM, Wellik KE, Wingerchuk DM, Demaerschalk BM. Establishing a diagnosis of benign paroxysmal positional vertigo through the Dix‐Hallpike and side‐lying maneuvers: a critically appraised topic. The Neurologist 2008;14(3):201‐4. [PUBMED: 18469678]

Handbook 2011

Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Helminski 2010

Helminski JO, Zee DS, Janssen I, Hain TC. Effectiveness of particle repositioning maneuvers in the treatment of benign paroxysmal positional vertigo: a systematic review. Physical Therapy 2010;90(5):663‐78.

Hunt 2012

Hunt WT, Zimmermann EF, Hilton MP. Modifications of the Epley (canalith repositioning) manoeuvre for posterior canal benign paroxysmal positional vertigo (BPPV). Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD008675.pub2]

Katsarkas 1978

Katsarkas A, Kirkham TH. Paroxysmal positional vertigo ‐ a study of 255 cases. Journal of Otolaryngology 1978;7(4):320‐30.

Mizukoshi 1988

Mizukoshi K, Watanabe Y, Shojaku H, Okubo J, Watanabe I. Epidemiological studies on benign paroxysmal positional vertigo in Japan. Acta Oto‐Laryngologica. Supplement 1988;447:67‐72.

Norre 1995

Norre ME. Reliability of examination data in the diagnosis of benign paroxysmal positional vertigo. American Journal of Otology 1995;16(6):806‐10.

Oghalai 2000

Oghalai JS, Manolidis S, Barth JL, Stewart MG, Jenkins HA. Unrecognized benign paroxysmal positional vertigo in elderly patients. Otolaryngology ‐ Head and Neck Surgery 2000;122(5):630‐4. [PUBMED: 10793337]

RevMan 2014 [Computer program]

The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Roberts 2006

Roberts RA, Gans RE, Montaudo RL. Efficacy of a new treatment maneuver for posterior canal benign paroxysmal positional vertigo. Journal of the American Academy of Audiology 2006;8:598‐604.

Semont 1988

Semont A, Freyss G, Vitte E. Curing the BPPV with a liberatory maneuver. Advances in Otorhinolaryngology 1988;42:290‐3.

von Brevern 2007

von Brevern M, Radtke A, Lezius F, Feldmann M, Ziese T, Lempert T, et al. Epidemiology of benign paroxysmal positional vertigo: a population based study. Journal of Neurology, Neurosurgery, and Psychiatry 2007;78(7):710‐5. [PUBMED: 17135456]

References to other published versions of this review

Hilton 2002

Hilton M, Pinder D. The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo. Cochrane Database of Systematic Reviews 2002, Issue 1. [DOI: 10.1002/14651858.CD003162]

Hilton 2004

Hilton MP, Pinder DK. The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo. Cochrane Database of Systematic Reviews 2004, Issue 2. [DOI: 10.1002/14651858.CD003162.pub2]

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Amor Dorado 2012

Methods

Allocation: prospective randomised controlled trial

Design: parallel

Participants

Number: 81 patients

Age: mean age 59

Gender: not reported

Setting: hospital otolaryngology department

Eligibility criteria: minimum duration of symptoms 1 week. Typical symptoms with positive Dix‐Hallpike test and no prior treatment for BPPV
Exclusion criteria: patients who did not develop typical nystagmus on Dix‐Hallpike testing, and previous cervical spine injury

Baseline characteristics: symptoms present for mean of 50/57 days prior to treatment. Greater proportion of men in Epley group (62%) versus Brandt‐Daroff group (39%) (P value = 0.05)

Interventions

Intervention group: modified Epley manoeuvre

n = 40

Comparator group: Brandt‐Daroff exercises (5 cycles, TDS for 1 week)

n = 41

Use of additional interventions: not reported

Outcomes

Primary outcome: percentage of patients with a negative Dix‐Hallpike test after treatment
Secondary outcomes:

1. Short‐ and long‐term recurrence of symptoms, assessed at 7 days, then 1, 6, 12, 24, 36 and 48 months

2. Adverse effects of treatment

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Computer‐generated

Allocation concealment (selection bias)

Low risk

Remote external allocation of group

Blinding (performance bias and detection bias)
All outcomes

Low risk

Assessor blind to treatment group

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Data are reported only for patients who had 48 months of follow‐up. It is unclear whether there was complete follow‐up, or whether this represented only a proportion of patients who were entered into the trial

Selective reporting (reporting bias)

Low risk

All outcomes reported

Other bias

Low risk

Bruintjes 2014

Methods

Allocation: randomised, double‐blind, sham‐controlled trial

Design: parallel allocation

Participants

Number: 44 patients

Age: mean age 59, all over 18

Gender: 18 male, 26 female

Setting: multidisciplinary dizziness clinic in teaching hospital

Eligibility criteria: typical history and classic Dix‐Hallpike test

Exclusion criteria; previous Epley treatment, cervical disc herniation, severe communication problem

Baseline characteristics: sham patients slightly older than Epley group (62.5 versus 55.7 years; P value = 0.08) and patients in Epley group had lower median DHI score (23 (range 8 to 66) versus 33 (range 16 to 72); P value = 0.08)

Interventions

Intervention group: modified Epley manoeuvre, repeated up to 2 times if persistent positive Dix‐Hallpike test

Control group: sham manoeuvre (similar to Semont diagnostic manoeuvre), repeated up to 2 times

All patients advised to sleep propped up for 48 hours and to avoid lying on affected side for 48 hours

Outcomes

Primary: proportion of patients with negative Dix‐Hallpike test at 12 months

Secondary:

1. Proportion of patients with negative Dix‐Hallpike test at 1, 3, 6 months

2. DHI

3. Adverse events

Notes

Sham manoeuvre is the same as a single Brandt‐Daroff manoeuvre

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Computer‐generated random sequence prior to study start

Allocation concealment (selection bias)

Low risk

Sealed envelope allocation

Blinding (performance bias and detection bias)
All outcomes

Low risk

Assessors and patients both blind to treatment group

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Losses accounted for; last observation carried forward method

Selective reporting (reporting bias)

Low risk

Outcomes pre‐defined and all reported

Other bias

Low risk

Dispenza 2012

Methods

Allocation: prospective randomised controlled trial

Design: parallel

Participants

Number: 88 patients

Age: 32 to 80 years

Gender: 40 males, 48 females

Setting: 2 tertiary hospital otolaryngology departments

Eligibility criteria: provocation test for BPPV was side‐lying manoeuvre, rather than Dix‐Hallpike test
Exclusion criteria: patients with multiple canal symptoms, whiplash, other causes of vertigo

Baseline characteristics: symptom duration from 5 days to 2 months

Interventions

Intervention group: modified Epley

n = 27

Comparator group: Semont versus 'hybrid' manoeuvre (defined in text)

n = 30/31

Treatment repeated in the initial session if persisting symptoms/signs on retesting

Use of additional interventions: patients retested immediately after treatment and manoeuvre performed again if needed

Outcomes

Primary outcome: persistence of nystagmus on repeat provocation testing at 1 week
Secondary outcomes:

1. Number of manoeuvres performed to clear symptoms at first visit

2. Adverse effects: discomfort of the manoeuvre(s)

Notes

Side‐lying test is applied less commonly than the Dix‐Hallpike test but applies the same physiological principles to the diagnosis in terms of individually challenging the posterior semicircular canals in turn (Halker 2008). The hybrid manoeuvre is an alternative particle repositioning manoeuvre (Roberts 2006). The trial report also includes data on a cohort of patients who were allocated (not randomised) to receive the hybrid manoeuvre because of co‐morbidity (e.g. obesity, neck problems). Data from these patients are presented separately in the paper and have not been included or addressed further in this review

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

States randomisation, but no details. Author contacted for clarification but no response

Allocation concealment (selection bias)

Unclear risk

As above

Blinding (performance bias and detection bias)
All outcomes

Low risk

Assessors blinded to treatment group

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No loss to follow‐up

Selective reporting (reporting bias)

High risk

Discomfort levels for Epley and Semont manoeuvres are not reported

Other bias

Low risk

Froehling 2000

Methods

Allocation: prospective randomised controlled trial; randomisation stratified by age and sex

Design: parallel

Participants

Number: 50 patients

Age: greater than 18 years old

Gender: 18 males, 32 females

Setting: hospital otolaryngology department

Eligibility criteria: positional vertigo and nystagmus on Hallpike testing
Exclusion criteria: bilateral disease, CNS disease, otitis media, otosclerosis, intolerant of Dix‐Hallpike manoeuvre

Baseline characteristics: median symptom duration 43 days for the experimental group, 35 days for the sham group

Interventions

Intervention group: modified Epley manoeuvre

n = 24

Comparator group: sham manoeuvre (lying on the affected side for 5 minutes)

n = 26

Use of additional interventions: not reported

Outcomes

Primary outcome:

Subjective improvement by question, "Do you feel your dizziness has completely resolved?"
Secondary outcomes:

Conversion of Dix‐Hallpike test from positive to negative

Notes

Follow‐up only at 1 to 2 weeks after treatment; no long‐term assessment

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Age/sex stratification suggests appropriate sequence generation

Allocation concealment (selection bias)

Low risk

Blinding (performance bias and detection bias)
All outcomes

Low risk

Assessor blinded to treatment; patients received realistic sham treatment

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No missing outcome data

Selective reporting (reporting bias)

Low risk

All outcomes reported

Other bias

Low risk

Liang 2010

Methods

Allocation: randomised controlled trial

Design: parallel

Participants

Number: 87 patients

Age: 43/42 mean age for treatment/control

Gender: 50 female, 37 male

Setting: hospital otolaryngology department

Eligibility criteria: patients included with a typical history of BPPV and positive Dix‐Hallpike test
Exclusion criteria: not reported

Baseline characteristics: symptom duration not specified

Interventions

Intervention group: Epley treatment plus medication

n = 43

Comparator group: medication only

n = 44

Use of additional interventions: not reported

Outcomes

Primary outcome: resolution of BPPV, categorical assignment as composite measure of symptom resolution and Dix‐Hallpike testing

‐ Cured (no vertigo, Dix‐Hallpike negative)

‐ Improved (vertigo improved, Dix‐Hallpike positive)

‐ No response

Secondary outcomes: none reported

Notes

For the purpose of analysis, the outcomes were collated to a dichotomous variable of 'resolved' (cured outcome group) or persisting symptoms ('improved' and 'no response' groups)

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Randomised, although no details

Allocation concealment (selection bias)

Unclear risk

No description of technique for allocation

Blinding (performance bias and detection bias)
All outcomes

Unclear risk

Not mentioned

Incomplete outcome data (attrition bias)
All outcomes

Low risk

All patients included in analysis

Selective reporting (reporting bias)

Low risk

All results reported

Other bias

Low risk

Lynn 1995

Methods

Allocation: prospective randomised controlled trial

Design: parallel

Participants

Number: 36 patients

Age: between 23 and 90 years

Gender: 9 males, 24 females

Setting: hospital otolaryngology department

Eligibility criteria: symptom duration for minimum 2 months
Exclusion criteria: bilateral disease

Baseline characteristics: no difference between groups in sex, median age, self report of dizziness severity, amount of time counselled

Interventions

Intervention group: modified Epley manoeuvre

n = 18

Comparator group: sham manoeuvre (lying in the first lateral position of the Semont manoeuvre for 5 minutes)

n = 15

Use of additional interventions: patients already taking medication for dizziness were allowed to continue

Outcomes

Primary outcome: resolution of symptoms. Daily diary of symptoms. Report of vertigo in the 7 days prior to reassessment at 1 month was "failure"
Secondary outcomes:

Conversion of Dix‐Hallpike test from positive to negative

Notes

Follow‐up only at 1 month after treatment; no long‐term assessment

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Block randomisation

Allocation concealment (selection bias)

Low risk

Sealed envelopes

Blinding (performance bias and detection bias)
All outcomes

Low risk

Assessor blinded. Patients experienced realistic, comparable sham treatment

Incomplete outcome data (attrition bias)
All outcomes

Low risk

3 of 36 patients with incomplete data. Appropriate explanation of drop‐out, spread between groups

Selective reporting (reporting bias)

Low risk

All outcomes reported

Other bias

Low risk

Mazoor 2011

Methods

Allocation: randomised controlled trial

Design: parallel

Participants

Number: 60 patients

Age: 20 to 75 years

Gender: 35 female, 25 male

Setting: hospital otolaryngology department

Eligibility criteria: typical history of BPPV and positive Dix‐Hallpike test
Exclusion criteria: patients with BPPV secondary to head injury and cervical spondylosis

Baseline characteristics: no minimum symptom duration stated

Interventions

Intervention group: modified Epley manoeuvre

n = 30

Comparator group: Semont manoeuvre

n = 30

Use of additional interventions: not reported

Outcomes

Primary outcome: negative Dix‐Hallpike test at day 3, 7 and 30

Secondary outcome: adverse effects of treatment

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Random number tables

Allocation concealment (selection bias)

High risk

Report states "allocated using random number tables". It is not clear from the paper whether the allocation and sequence from the tables was concealed

Blinding (performance bias and detection bias)
All outcomes

High risk

None

Incomplete outcome data (attrition bias)
All outcomes

Low risk

All reported

Selective reporting (reporting bias)

Low risk

All reported

Other bias

Low risk

Munoz 2007

Methods

Allocation: prospective, double‐blind, randomised controlled trial

Design: parallel

Participants

Number: 81 patients

Age: over 18 years of age

Gender: 56 female, 23 male

Setting: academic family practice in Canada

Eligibility criteria: eligible if self report of positional vertigo with a positive unilateral Dix‐Hallpike test
Exclusion criteria: central nervous system disease, otitis media, otosclerosis, inability to tolerate the manoeuvre, severe cervical spine or cardiac disease

Baseline characteristics: higher proportion of female patients in the treatment group than control (81% versus 61%)

Interventions

Intervention group: standard Epley treatment

n = 38

Comparator group: sham treatment (the sham treatment was an Epley manoeuvre performed as if opposite ear was affected)

n = 41

Use of additional interventions: not reported

Outcomes

Primary outcome:

Subjective resolution of symptoms on Dix‐Hallpike testing
Secondary outcomes:

Conversion of Dix‐Hallpike test from positive to negative

Notes

The patients were immediately re‐tested with a Dix‐Hallpike test after the treatment. It is this result reported in the outcome.

We contacted the senior author for clarification. Patients were tested prior to their second treatment, i.e. 1 week following their first treatment (and before the 2nd treatment). Results for these tests were requested but have not been provided.

The full trial report details include 2 follow‐up visits. However, patients in the sham treatment group all had conventional Epley treatment at the 2nd visit (if still symptomatic) and data from these subsequent visits are not included in the analysis

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Computer‐generated

Allocation concealment (selection bias)

Low risk

Central telephone allocation

Blinding (performance bias and detection bias)
All outcomes

Low risk

Testing and assessment by a physician who had not administered the treatment, and was blind to study group

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Test results were immediately post‐treatment, and available for all patients

Selective reporting (reporting bias)

Unclear risk

Both outcomes are reported for the immediate post‐test assessment. It is unclear why results performed before the 2nd intervention were not included

Other bias

Low risk

von Brevern 2006

Methods

Allocation: prospective, double‐blind, randomised controlled trial

Design: parallel

Participants

Number: 67 patients

Age: 19 to 86 years

Gender: 19 male, 47 female

Setting: hospital otolaryngology department

Eligibility criteria: a typical history of positional vertigo combined with a typical pattern and latency of associated nystagmus on Dix‐Hallpike testing
Exclusion criteria: bilateral disease, anterior or horizontal canal BPPV, treatment with Epley manoeuvre previously during this episode of BPPV

Baseline characteristics: no baseline difference in groups

Interventions

Intervention group: Epley manoeuvre

n = 36

Comparator group: sham treatment (the sham treatment was an Epley manoeuvre performed as if opposite ear was affected)

n = 31
Use of additional interventions: not reported

Outcomes

Primary outcome:

Absence of symptoms on repeat Dix‐Hallpike testing after 24 hours
Secondary outcomes:

Change of Dix‐Hallpike test from positive to negative at 24 hours

Notes

Follow‐up period and testing was only 24 hours. Stated aim was to reduce likelihood of any spontaneous resolution in the control (sham) group

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Computer‐generated randomised numbers

Allocation concealment (selection bias)

Low risk

Sealed envelope allocation

Blinding (performance bias and detection bias)
All outcomes

Low risk

The assessor at 24 hours was blinded to the treatment group. Patients were unaware if they were in the treatment or sham group

Incomplete outcome data (attrition bias)
All outcomes

Low risk

1 drop‐out in study

Selective reporting (reporting bias)

Low risk

Both stated outcomes fully reported

Other bias

Unclear risk

No explanation for disparity in number of patients in treatment versus control groups (58 versus 45)

Xie 2012

Methods

Allocation: randomised controlled trial

Design: parallel

Participants

Number: 103 patients

Age: range 20 to 84

Gender: 65 female, 38 male

Setting: family practice

Eligibility criteria: a typical history of BPPV and positive Dix‐Hallpike test
Exclusion criteria: not reported

Baseline characteristics: symptom duration not specified

Interventions

Intervention group: modified Epley treatment plus postural restrictions

n = 58

Comparator group: postural restrictions only

n = 45

Use of additional interventions: not reported

Outcomes

Primary outcome: resolution of BPPV, categorical assignment as composite measure of symptom resolution and Dix‐Hallpike testing

‐ Cured (no vertigo, Dix‐Hallpike negative)

‐ Improved (vertigo improved, Dix‐Hallpike positive)

‐ No response

Secondary outcomes: none reported

Notes

For the purpose of analysis, the outcomes were collated to a dichotomous variable of 'resolved' (cured outcome group) or persisting symptoms ('improved' and 'no response' groups)

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

States randomised but no details

Allocation concealment (selection bias)

High risk

No details given of methods to conceal allocation

Blinding (performance bias and detection bias)
All outcomes

High risk

No blinding of assessors mentioned

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Patient data all reported

Selective reporting (reporting bias)

Low risk

Results all reported

Other bias

Low risk

Yimtae 2003

Methods

Allocation: prospective randomised controlled trial; block randomisation by symptom duration

Design: parallel

Participants

Number: 58 patients

Age: greater than 18 years old

Gender: 43 female, 15 male

Setting: hospital neuro‐otology department

Eligibility criteria: typical history of vertigo with positive Dix‐Hallpike test
Exclusion criteria: neck problems, unstable cardiopulmonary problems

Baseline characteristics: 31 versus 39 days of symptoms. No other group difference

Interventions

Intervention group: modified Epley manoeuvre

n = 29

Comparator group: untreated control

n = 29

Use of additional interventions: not reported

Outcomes

Primary outcome: resolution of vertigo
Secondary outcomes:

Conversion of Dix‐Hallpike test from positive to negative
Medication (cinnarizine) taken during study period

Notes

Follow‐up weekly for 1 month

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Block randomisation strongly implies robust strategy. Stratified by duration of symptoms

Allocation concealment (selection bias)

Low risk

Blinding (performance bias and detection bias)
All outcomes

Low risk

Assessor blinded to treatment group

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No missing data

Selective reporting (reporting bias)

Low risk

All outcomes reported

Other bias

Low risk

Small potential for bias ‐ patients in the control group were untreated, and did not therefore have a similar experience of receiving 'therapeutic' intervention

All 10 trials applied a modified Epley manoeuvre: the sequence of positioning was as originally described by Epley 1992, but without the addition of mastoid oscillation or premedication.

BPPV: benign paroxysmal positional vertigo
CNS: central nervous system
DHI: Dizziness Handicap Inventory
TDS: three times a day

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Angeli 2003

ALLOCATION:
Randomised, controlled

PARTICIPANTS:
47 patients (>/= 70 years old) with the diagnosis of unilateral posterior semicircular canal BPPV

INTERVENTIONS:
The canalith repositioning manoeuvre described is fundamentally different from the Epley manoeuvre

Arbağ 2003

ALLOCATION:

Patients were allocated to groups; strategy unclear but randomisation not mentioned in text and authors did not reply to request for information

Asawavichianginda 2000

ALLOCATION:
1. No blinding of outcome assessors
2. Performance bias: control group received no exposure to clinical staff during the trial other than assessments, compared to frequent attendance in experimental group

PARTICIPANTS:
Short duration of symptoms: 62% of cohort reported symptoms of less than 2 weeks duration

Blakley 1994

ALLOCATION:
1. Inadequate randomisation strategy
2. No blinding of outcome assessors
3. Performance bias: control group received less exposure to clinical staff

OUTCOME MEASURES:
Outcome only by subjective measures

Cohen 1999

ALLOCATION:
1. Inadequate randomisation strategy ‐ sequential allocation
2. No blinding of outcome assessors
3. Risk of attrition bias: complete follow‐up for only 58 of 87 participants

OUTCOME MEASURES:
Outcome only by subjective measures

Cohen 2005

ALLOCATION:

Randomisation was a computer‐generated spreadsheet, but patients were then sequentially allocated to groups as they attended (see similar, Cohen 1999)

Herdman 1993

ALLOCATION:
1. Unclear randomisation strategy
2. No blinding of outcome assessors

OUTCOME MEASURES:
Objective outcome measures (Dix‐Hallpike test) reported in only 48% of participants

Li 1995

ALLOCATION:
1. Unclear randomisation strategy
2. No blinding of outcome assessors

Massoud 1996

ALLOCATION:
1. Unclear randomisation strategy
2. No blinding of outcome assessors

Radtke 1999

ALLOCATION:
1. Inadequate randomisation: 20% of the study population were allocated to receive the Epley manoeuvre because they had previously failed with rehabilitation exercises, which was the control treatment. Remaining patients were allocated alternately
2. No blinding of outcome assessors

Sekine 2006

ALLOCATION:
1. No randomisation or concealed allocation. Patients were allocated to treatment group according to which of 2 institutions they attended
2. Patients and researchers were not blinded to intervention group

Seo 2007

ALLOCATION:
Sequential allocation to groups. High risk of bias ‐ no allocation concealment

Sherman 2001

ALLOCATION:
1. Inadequate randomisation; allocation by date of clinic visit
2. High drop‐out rate

Soto Varela 2001

ALLOCATION:
1. No description of randomisation strategy
2. Assessors not blinded to treatment group

Sridhar 2003

ALLOCATION:
Assessors were not blinded to treatment group of patient

Steenerson 1996

ALLOCATION:
1. Inadequate randomisation: alternative allocation to 2 treatment groups. Control group were patients who refused active treatment
2. No blinding of outcome assessors

OUTCOME MEASURES:
No objective outcome measure

Waleem 2008

ALLOCATION:
High risk of bias in assignment of patients to study groups. Patients were allocated by non‐probability convenience sampling

Wolf 1999

ALLOCATION:
1. Inadequate randomisation: first 22 patients allocated by date of examination (odd/even). Remaining 19 patients all received active treatment
2. No blinding of outcome assessors
3. Performance bias: control group received less exposure to clinical staff

BPPV: benign paroxysmal positional vertigo

Characteristics of studies awaiting assessment [ordered by study ID]

Dashti Gholamali 2010

Methods

Randomised controlled trial

Participants

38 patients (22 female, 16 male) aged 23 to 56 years

Interventions

Epley versus Semont manoeuvre

Outcomes

Primary outcome measure: resolution of vertigo and negative Dix‐Hallpike test

Notes

Reference not obtainable

Abstract details insufficient for data analysis. No detail of inclusion/exclusion criteria. Recovery rates expressed as percentages, not numbers of patients with no indication of loss to follow‐up

Okhovat 2003

Methods

Randomised controlled trial

Participants

130 patients (65:65)

Interventions

Epley treatment versus Semont manoeuvres

Outcomes

Primary outcome measure: resolution of vertigo and negative Dix‐Hallpike test

Secondary outcome measure: simplicity of performing the manoeuvre

Notes

Reference not obtainable

Abstract details insufficient for data analysis. No detail of inclusion/exclusion criteria. Recovery rates expressed as percentages, not numbers of patients with no indication of loss to follow‐up

Data and analyses

Open in table viewer
Comparison 1. Epley versus control or placebo manoeuvre

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Complete resolution of vertigo symptoms (subjective report) Show forest plot

5

273

Odds Ratio (M‐H, Fixed, 95% CI)

4.42 [2.62, 7.44]

Analysis 1.1

Comparison 1 Epley versus control or placebo manoeuvre, Outcome 1 Complete resolution of vertigo symptoms (subjective report).

Comparison 1 Epley versus control or placebo manoeuvre, Outcome 1 Complete resolution of vertigo symptoms (subjective report).

2 Conversion of a positive to a negative Dix‐Hallpike test Show forest plot

8

507

Odds Ratio (M‐H, Fixed, 95% CI)

9.62 [6.00, 15.42]

Analysis 1.2

Comparison 1 Epley versus control or placebo manoeuvre, Outcome 2 Conversion of a positive to a negative Dix‐Hallpike test.

Comparison 1 Epley versus control or placebo manoeuvre, Outcome 2 Conversion of a positive to a negative Dix‐Hallpike test.

Open in table viewer
Comparison 2. Epley versus Brandt‐Daroff exercises

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Resolution of symptoms and nystagmus on Dix‐Hallpike test Show forest plot

1

81

Odds Ratio (M‐H, Fixed, 95% CI)

12.38 [4.32, 35.47]

Analysis 2.1

Comparison 2 Epley versus Brandt‐Daroff exercises, Outcome 1 Resolution of symptoms and nystagmus on Dix‐Hallpike test.

Comparison 2 Epley versus Brandt‐Daroff exercises, Outcome 1 Resolution of symptoms and nystagmus on Dix‐Hallpike test.

Open in table viewer
Comparison 3. Epley versus Semont manoeuvre

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Resolution of nystagmus on provocation testing, at 7 days Show forest plot

2

117

Odds Ratio (M‐H, Fixed, 95% CI)

0.78 [0.32, 1.88]

Analysis 3.1

Comparison 3 Epley versus Semont manoeuvre, Outcome 1 Resolution of nystagmus on provocation testing, at 7 days.

Comparison 3 Epley versus Semont manoeuvre, Outcome 1 Resolution of nystagmus on provocation testing, at 7 days.

Open in table viewer
Comparison 4. Epley versus hybrid (Gans) manoeuvre

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Resolution of nystagmus on provocation testing, at 7 days Show forest plot

1

58

Odds Ratio (M‐H, Fixed, 95% CI)

0.67 [0.18, 2.52]

Analysis 4.1

Comparison 4 Epley versus hybrid (Gans) manoeuvre, Outcome 1 Resolution of nystagmus on provocation testing, at 7 days.

Comparison 4 Epley versus hybrid (Gans) manoeuvre, Outcome 1 Resolution of nystagmus on provocation testing, at 7 days.

Study flow diagram.
Figuras y tablas -
Figure 1

Study flow diagram.

'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.
Figuras y tablas -
Figure 2

'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.

Comparison 1 Epley versus control or placebo manoeuvre, Outcome 1 Complete resolution of vertigo symptoms (subjective report).
Figuras y tablas -
Analysis 1.1

Comparison 1 Epley versus control or placebo manoeuvre, Outcome 1 Complete resolution of vertigo symptoms (subjective report).

Comparison 1 Epley versus control or placebo manoeuvre, Outcome 2 Conversion of a positive to a negative Dix‐Hallpike test.
Figuras y tablas -
Analysis 1.2

Comparison 1 Epley versus control or placebo manoeuvre, Outcome 2 Conversion of a positive to a negative Dix‐Hallpike test.

Comparison 2 Epley versus Brandt‐Daroff exercises, Outcome 1 Resolution of symptoms and nystagmus on Dix‐Hallpike test.
Figuras y tablas -
Analysis 2.1

Comparison 2 Epley versus Brandt‐Daroff exercises, Outcome 1 Resolution of symptoms and nystagmus on Dix‐Hallpike test.

Comparison 3 Epley versus Semont manoeuvre, Outcome 1 Resolution of nystagmus on provocation testing, at 7 days.
Figuras y tablas -
Analysis 3.1

Comparison 3 Epley versus Semont manoeuvre, Outcome 1 Resolution of nystagmus on provocation testing, at 7 days.

Comparison 4 Epley versus hybrid (Gans) manoeuvre, Outcome 1 Resolution of nystagmus on provocation testing, at 7 days.
Figuras y tablas -
Analysis 4.1

Comparison 4 Epley versus hybrid (Gans) manoeuvre, Outcome 1 Resolution of nystagmus on provocation testing, at 7 days.

Comparison 1. Epley versus control or placebo manoeuvre

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Complete resolution of vertigo symptoms (subjective report) Show forest plot

5

273

Odds Ratio (M‐H, Fixed, 95% CI)

4.42 [2.62, 7.44]

2 Conversion of a positive to a negative Dix‐Hallpike test Show forest plot

8

507

Odds Ratio (M‐H, Fixed, 95% CI)

9.62 [6.00, 15.42]

Figuras y tablas -
Comparison 1. Epley versus control or placebo manoeuvre
Comparison 2. Epley versus Brandt‐Daroff exercises

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Resolution of symptoms and nystagmus on Dix‐Hallpike test Show forest plot

1

81

Odds Ratio (M‐H, Fixed, 95% CI)

12.38 [4.32, 35.47]

Figuras y tablas -
Comparison 2. Epley versus Brandt‐Daroff exercises
Comparison 3. Epley versus Semont manoeuvre

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Resolution of nystagmus on provocation testing, at 7 days Show forest plot

2

117

Odds Ratio (M‐H, Fixed, 95% CI)

0.78 [0.32, 1.88]

Figuras y tablas -
Comparison 3. Epley versus Semont manoeuvre
Comparison 4. Epley versus hybrid (Gans) manoeuvre

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Resolution of nystagmus on provocation testing, at 7 days Show forest plot

1

58

Odds Ratio (M‐H, Fixed, 95% CI)

0.67 [0.18, 2.52]

Figuras y tablas -
Comparison 4. Epley versus hybrid (Gans) manoeuvre